| 000 | 00893nam a2200265 a 4500 | ||
|---|---|---|---|
| 005 | 20250914164014.0 | ||
| 008 | 080318s2007 ne 000 0 eng d | ||
| 020 |
_a9780444521736 _cRM421.20 |
||
| 039 | 9 |
_a200809040848 _bazhari _c200807241108 _dazhari _c200807241107 _dazhari _c200805291542 _dazhari _y03-18-2008 _zfida |
|
| 040 | _aUKM | ||
| 060 |
_aQV268.5 _b.A244 2007 9 |
||
| 090 | _aQV268.5.A244 2007 9 | ||
| 245 | 0 | 0 |
_aAdvances in antiviral drug design / _ceditor: E. De Clercq |
| 260 |
_aAmsterdam ; London : _bElsevier, _c2007 |
||
| 300 |
_axi, 251 p. : _bill. ; _c25 cm. |
||
| 650 | 2 | _aAntiviral agents | |
| 700 | 1 | _aClercq, E. De | |
| 907 |
_a.b14087893 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV268.5.A244 2007 9 |
||
| 914 | _avtls003366094 | ||
| 990 | _aazh | ||
| 991 | _aJabatan Farmakologi | ||
| 998 |
_ad _b2008-05-03 _cm _da _feng _gne _y0 _z.b14087893 |
||
| 999 |
_c404836 _d404836 |
||